Terminated PHASE4 INTERVENTIONAL 3-arm NCT03694821

Knee Injection RCT

Efficacy and Cost-effectiveness of Intra-Articular Ketorolac Injection for Knee Osteoarthritis: A Randomized, Controlled, Double-Blinded Study

Sponsor: Orthopedic Research and Education Foundation

Conditions Osteoarthritis

Interventions Hylan G-F 20 Ketorolac Tromethamine Injection Methylprednisolone Acetate Injection

Updated 5 times since 2018 Last updated: Feb 5, 2020 Started: Jul 5, 2018 Primary completion: Jul 16, 2019 Completion: Jul 16, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low enrollment

Other terminated trials from Orthopedic Research and Education Foundation

See all terminations from Orthopedic Research and Education Foundation

Other Osteoarthritis trials with similar outcome

Browse all Osteoarthritis trials

This PHASE4 trial investigates Osteoarthritis and is currently terminated or withdrawn. Orthopedic Research and Education Foundation leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Mar 2020 — Jan 2021 [monthly]

Terminated PHASE4

Status: Enrolling By Invitation → Terminated
Nov 2018 — Mar 2020 [monthly]

Enrolling By Invitation PHASE4

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Orthopedic Research and Education Foundation
UConn Health

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farmington, United States